Description of Blood Analysis:

The Epstein-Barr Virus (EBV) Viral Capsid Antigen (VCA) IgG test is a laboratory study used to detect specific antibodies produced by the immune system in response to the virus. VCA IgG antibodies typically appear during the acute phase of infectious mononucleosis, reach their maximum concentration within weeks, and persist for life, serving as a marker of immune memory. In clinical practice, this analysis is used to determine if a patient has previously encountered the virus or is currently in a late stage of the infection process.

What does the analysis represent?

• Purpose: Quantitative or qualitative measurement of IgG antibodies to the viral capsid antigen of EBV in blood serum.
• Primary Application: Assessment of long-term immunity and retrospective diagnosis of infectious mononucleosis.
• Method: High-precision immunochemical study (ELISA or CLIA) of a venous blood sample.

Recommendations for the test (General)

• Timing: Recommended for the morning, usually between 8:00 and 11:00 AM.
• Fasting: A fasting pause of at least 4–8 hours is required; plain water is allowed.
• Preparation: Avoid intensive physical exertion and alcohol consumption 24 hours before the blood draw.

What can affect the results?

• Infectious Window: If the test is performed too early after exposure, the IgG levels may still be undetectable.
• Immune Status: Patients with severe immunosuppression may have a delayed or weakened antibody response, leading to potentially misleading results.

When to take the test?

• Indications: Symptoms of infectious mononucleosis (fever, lymphadenopathy, sore throat), chronic fatigue syndrome, or screening for immune status.
• Monitoring: Used in the differential diagnosis of various viral and hematological conditions.

How to interpret the results?

The interpretation of laboratory data is the exclusive responsibility of an infectious disease specialist or an immunologist. A positive result for VCA IgG, when considered alongside other clinical data, usually indicates a past infection and lifelong immunity. The physician evaluates this marker in combination with VCA IgM and EBNA IgG to accurately determine the stage of the viral process and the patient’s current health status.

Possible further investigations

• EBV VCA IgM: A crucial marker to rule out or confirm an ongoing acute primary infection.
• EBV EBNA IgG: Performed to confirm that the infection occurred more than 3–6 months ago.
• Complete Blood Count (CBC): To identify characteristic changes such as lymphocytosis or atypical mononuclear cells.

When does the next step make sense?

Results are reviewed by a physician in the context of the patient’s symptoms and medical history. If the test is part of a routine screening, the findings help establish the baseline immune status. If symptoms are present, the doctor will determine the need for supportive therapy or further diagnostic steps to rule out other conditions.

👉 If necessary, you can discuss the test results with our specialized — immunologist disease specialist (Doctors – TAMC).